Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-26-001247
Filing Date
2026-03-13
Accepted
2026-03-13 16:11:30
Documents
2
Period of Report
2026-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 7409
2 POWER OF ATTORNEY poa_urban.htm EX-24 13513
  Complete submission text file 0000905148-26-001247.txt   22359
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 TALCOTT AVE. 2ND FLOOR WATERTOWN MA 02472
Business Address
Urban Michael J. (Reporting) CIK: 0002118666 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 26752535